Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13 | -320 | 396 | 139 | -3 |
| Depreciation Amortization | 83 | 440 | 250 | 162 | 0 |
| Accounts receivable | 7 | -651 | -1,140 | -1,296 | N/A |
| Other Working Capital | -548 | -881 | -1,065 | -819 | -4 |
| Other Operating Activity | 9 | 1,150 | 1,174 | 1,342 | 1 |
| Operating Cash Flow | $-462 | $-261 | $-386 | $-473 | $-6 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -358 | -352 | -53 | N/A |
| Investing Cash Flow | $-25 | $-358 | $-352 | $-53 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,657 | N/A | N/A | N/A | N/A |
| Debt Repayment | -30 | -92 | -94 | -102 | N/A |
| Other Financing Activity | -152 | 375 | 377 | 251 | 0 |
| Financing Cash Flow | $2,475 | $283 | $283 | $149 | $N/A |
| Beginning Cash Position | 252 | 587 | 631 | 631 | 43 |
| End Cash Position | 2,240 | 252 | 174 | 254 | 37 |
| Net Cash Flow | $1,988 | $-336 | $-456 | $-377 | $-7 |
| Free Cash Flow | |||||
| Operating Cash Flow | -462 | -261 | -386 | -473 | -6 |
| Capital Expenditure | -25 | -358 | -352 | -53 | N/A |
| Free Cash Flow | -487 | -619 | -739 | -525 | -6 |